The effects of aging on lung structure and function
GS Skloot - Clinics in geriatric medicine, 2017 - geriatric.theclinics.com
There are now more Americans older than 65 years than at any other point in US history,
and the aging population is expected to increase rapidly over the next decade. 1 Aging …
and the aging population is expected to increase rapidly over the next decade. 1 Aging …
Combined pulmonary fibrosis and emphysema (CPFE) clinical features and management
R Hage, F Gautschi, C Steinack… - International Journal of …, 2021 - Taylor & Francis
Background Combined pulmonary fibrosis and emphysema (CPFE) is an underrecognized
syndrome characterized by chronic, progressive disease with a dismal prognosis. Frequent …
syndrome characterized by chronic, progressive disease with a dismal prognosis. Frequent …
[HTML][HTML] Association of heart diseases with COPD and restrictive lung function–results from a population survey
B Eriksson, A Lindberg, H Müllerova, E Rönmark… - Respiratory …, 2013 - Elsevier
INTRODUCTION: Few studies have explored the association of COPD, based on GOLD
definition, with heart diseases. The relationship between restrictive lung function impairment …
definition, with heart diseases. The relationship between restrictive lung function impairment …
Current clinical management of pulmonary arterial hypertension
RT Zamanian, KT Kudelko, YK Sung… - Circulation …, 2014 - Am Heart Assoc
During the past 2 decades, there has been a tremendous evolution in the evaluation and
care of patients with pulmonary arterial hypertension (PAH). The introduction of targeted …
care of patients with pulmonary arterial hypertension (PAH). The introduction of targeted …
The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis
AA Kulkarni, TH Thatcher, HM Hsiao, KC Olsen… - PloS one, 2013 - journals.plos.org
Pulmonary Fibrosis (PF) is a devastating progressive disease in which normal lung structure
and function is compromised by scarring. Lung fibrosis can be caused by thoracic radiation …
and function is compromised by scarring. Lung fibrosis can be caused by thoracic radiation …
[HTML][HTML] Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?
E de Pablo, R Fernández-García… - Annals of …, 2017 - ncbi.nlm.nih.gov
Nebulised antibiotics offer great advantages over intravenously administered antibiotics and
other conventional antibiotic formulations. However, their use is not widely standardized in …
other conventional antibiotic formulations. However, their use is not widely standardized in …
[HTML][HTML] Combined pulmonary fibrosis and emphysema: the many aspects of a cohabitation contract
Combined pulmonary fibrosis and emphysema (CPFE) is a clinical entity characterized by
the coexistence of upper lobe emphysema and lower lobe fibrosis. Patients with this …
the coexistence of upper lobe emphysema and lower lobe fibrosis. Patients with this …
[HTML][HTML] Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema
F Dong, Y Zhang, F Chi, Q Song, L Zhang… - … Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
The study aim was to explore the clinical efficacy and safety of inhaled corticosteroids
(ICS)/long-acting beta2-agonists (LABA) in combined with idiopathic pulmonary fibrosis and …
(ICS)/long-acting beta2-agonists (LABA) in combined with idiopathic pulmonary fibrosis and …
Ultrasonic evaluation of diaphragm in patients with systemic sclerosis
A Ljilja Posavec, S Hrkač, J Tečer… - Journal of personalized …, 2023 - mdpi.com
The diaphragm is the most important muscle in respiration. Nevertheless, its function is
rarely evaluated. Patients with systemic sclerosis (SSc) could be at risk of diaphragmatic …
rarely evaluated. Patients with systemic sclerosis (SSc) could be at risk of diaphragmatic …
[PDF][PDF] ICS/LABA 复合吸入治疗肺纤维化合并肺气肿综合征患者的临床效果
王志强， 王美华， 何雪琨， 于文成 - 精准医学杂志, 2022 - jpmed.qdu.edu.cn
目的探讨糖皮质激素联合支气管扩张剂(ICS/LABA) 吸入治疗肺纤维化合并肺气肿综合征(CPFE
) 患者的临床效果, 并对不同表型(吸烟相关性CPFE, 结缔组织病相关性CPFE) …
) 患者的临床效果, 并对不同表型(吸烟相关性CPFE, 结缔组织病相关性CPFE) …